Repligen (RGEN) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $130.59 -2.06%
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +21.6%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $19.8 million versus the consensus estimate of $20.5 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- The Lovesac Company (LOVE) Tops Q1 EPS by 29c
- UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
